Studies on neutralization of L-asparaginase activity in vitro and in vivo.
D000818:Animals; D000917:Antibody Formation; D001215:Asparaginase / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D007106:Immune Sera; D007108:Immune Tolerance; D005779:Immunodiffusion; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D011817:Rabbits; D014184:Transplantation, Homologous
D007106:Immune Sera; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001215:Asparaginase